Healthcare Industry News:  GE Capital 

Devices Venture Capital

 News Release - April 7, 2008

Pulse Health Closes $2.15 M Series A Funding Round

Keiretsu Forum Members Invest in Free Radical Breathalyzer Test

SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network)--Apr 7, 2008 -- Keiretsu Forum, the world's largest angel investment community, announces its members' investment in Pulse Health, the Portland, Oregon-based company that has developed the first breathalyzer test to measure free radicals.

After presenting to all four Bay Area Keiretsu Forum chapters, all four Northwest chapters, and at the Palm Springs Angel Capital Expo in January, Pulse Health closed its Series A funding round and raised $2.15 million. Keiretsu Forum members staked the round with $450,000 in funding, which will enable Pulse Health to continue the research, development, and sales of its flagship product, which is scheduled to launch by the end of 2008.

"The Keiretsu Forum process is extremely effective," said Pulse Health Founder David Urman. "The percentage of active investors in the membership is high, the feedback is rapid, and the staff quality is exceptional."

Keiretsu Forum offers a structured approach to private equity investing by providing a forum for like-minded business leaders to work together and assess investment opportunities and then make individual investment decisions.

About Keiretsu Forum

With 16 chapters and over 750 accredited investor members on three continents Keiretsu Forum (www.keiretsuforum.com) is the world's largest angel investment network. Keiretsu Forum members provide early-staGE Capital in the range of $250k-$2 million to high quality, diverse investment opportunities and collaborate in the due diligence, but make their own individual investment decisions.


Source: Keiretsu Forum

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.